You are here

Article info

Article menu
Download PDFPDF
Innovations
Treatment of diffuse subretinal fibrosis uveitis with rituximab

Authors

  • Kurt Spiteri Cornish Clinical Ophthalmology Department, NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, UK PubMed articlesGoogle scholar articles
  • Lucia Kuffova Clinical Ophthalmology Department, NHS Grampian, Aberdeen Royal Infirmary, Aberdeen, UK Section of Immunology, Inflammation and Infection (3I's) (Ocular Immunology), Division of Applied Medicine, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK PubMed articlesGoogle scholar articles
  • John V Forrester Section of Immunology, Inflammation and Infection (3I's) (Ocular Immunology), Division of Applied Medicine, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK Immunology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Kurt Spiteri Cornish, Ophthalmology Department, Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK; kspitericornish{at}nhs.net
View Full Text

Citation

Spiteri Cornish K, Kuffova L, Forrester JV
Treatment of diffuse subretinal fibrosis uveitis with rituximab
British Journal of Ophthalmology 2015;99:153-154.

Publication history

  • Received November 25, 2013
  • Revised February 10, 2014
  • Accepted April 29, 2014
  • First published May 30, 2014.
Online issue publication 
March 22, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions